Related Experiment Video
Updated: Aug 21, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretrovirals as antimalarial agents
Tina S Skinner-Adams1, James S McCarthy, Donald L Gardiner
1Malaria Biology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research and School of Population Health, University of Queensland, St. Lucia, Queensland, Australia.
Abstract:
Recent studies have indicated that antiretroviral protease inhibitors may affect outcome in malarial disease. We have investigated the antimalarial activities of 6 commonly used antiretroviral agents. Our data indicate that, in addition to the previously published effects on cytoadherence and phagocytosis, the human immunodeficiency virus (HIV)-1 protease inhibitors saquinavir, ritonavir, and indinavir directly inhibit the growth of Plasmodium falciparum in vitro at clinically relevant concentrations. These findings are particularly important in light of both the high rate of malaria and HIV-1 coinfection in sub-Saharan Africa and the effort to employ highly active antiretroviral therapy in these regions.
Insights
Certain HIV protease inhibitors, including saquinavir, ritonavir, and indinavir, directly inhibit the growth of malaria parasites (Plasmodium falciparum) in laboratory settings. This discovery is crucial for regions with high rates of HIV and malaria coinfection.
Area of Science:
- Infectious Diseases
- Pharmacology
- Tropical Medicine
Background:
- Antiretroviral protease inhibitors are used to treat HIV infection.
- Emerging evidence suggests these drugs may influence malaria outcomes.
- Understanding drug interactions is critical in coinfected populations.
Purpose of the Study:
- To investigate the antimalarial activity of commonly used antiretroviral agents.
- To determine if specific HIV protease inhibitors directly inhibit Plasmodium falciparum growth.
- To assess the relevance of these findings in clinical contexts.
Main Methods:
- In vitro testing of six antiretroviral agents against Plasmodium falciparum.
- Evaluation of drug effects at clinically relevant concentrations.
- Review of existing literature on protease inhibitor effects on parasite cytoadherence and phagocytosis.
Main Results:
- Saquinavir, ritonavir, and indinavir demonstrated direct inhibition of Plasmodium falciparum growth in vitro.
- These effects were observed at concentrations achievable in patients.
- Previous findings on cytoadherence and phagocytosis were corroborated.
Conclusions:
- Specific human immunodeficiency virus (HIV)-1 protease inhibitors possess direct antimalarial activity.
- These findings have significant implications for managing malaria and HIV coinfection in sub-Saharan Africa.
- Further research into these drug interactions is warranted for therapeutic strategies.
Related Concept Videos
Retrovirus Life Cycles
Antiprotozoal Agents
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Anthelminthic Agents
Inhibitors of Virion Maturation and Assembly

